Arrowhead Buys RNAi Research and Development Assets From Novartis
socalTECH
MARCH 5, 2015
Pasadena-based Arrowhead Research said this morning that it has acquired the entire RNAI research and development portfolio and associated assets of Novartis. Arrowhead said the deal also includes milestones and royalties on sales of future products. READ MORE>>.
Let's personalize your content